Patient Portal Doctor's Appointment Faculty and Staff Courses & Admissions News and Events Projects Publications Newsletters Careers

Accessibility

Font Size

Grey Scale

Patient Portal Doctor's Appointment Faculty and Staff Courses & Admissions News and Events Projects Publications Newsletters Careers

Languages

English हिन्दी ಕನ್ನಡ

Research

Medical Courses Nursing Courses Allied Health Science Courses

Publications

Home / Publications / Librexia AF is a randomized study to evaluate the efficacy and safety of mlivexian versus apixaban in atrial fibrillation.

Librexia AF is a randomized study to evaluate the efficacy and safety of mlivexian versus apixaban in atrial fibrillation.

Dr. Asha Thomas, Senior Scientist, Division of Epidemiology

The Impact of Urban Nutrition Transition on Adolescent Health in South India 2024

Tenders Statutory Institutional Policies Terms & Conditions Disclaimer Privacy Policy